Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
===============================================================================================================================

* Elizabeth I. Buchbinder
* Janice P. Dutcher
* Gregory A. Daniels
* Brendan D. Curti
* Sapna P. Patel
* Shernan G. Holtan
* Gerald P. Miletello
* Mayer N. Fishman
* Rene Gonzalez
* Joseph I. Clark
* John M. Richart
* Christopher D. Lao
* Scott S. Tykodi
* Ann W. Silk
* David F. McDermott